Merit Medical Systems Pre-Tax Profit Margin 2010-2024 | MMSI
Current and historical pre-tax profit margin for Merit Medical Systems (MMSI) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Merit Medical Systems pre-tax profit margin for the three months ending September 30, 2024 was .
Merit Medical Systems Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2024-09-30 |
$1.33B |
$0.15B |
11.15% |
2024-06-30 |
$1.30B |
$0.14B |
10.83% |
2024-03-31 |
$1.28B |
$0.12B |
9.35% |
2023-12-31 |
$1.26B |
$0.11B |
8.90% |
2023-09-30 |
$1.23B |
$0.11B |
9.05% |
2023-06-30 |
$1.20B |
$0.10B |
8.26% |
2023-03-31 |
$1.17B |
$0.10B |
8.10% |
2022-12-31 |
$1.15B |
$0.08B |
7.22% |
2022-09-30 |
$1.14B |
$0.07B |
6.43% |
2022-06-30 |
$1.12B |
$0.07B |
6.19% |
2022-03-31 |
$1.10B |
$0.06B |
5.00% |
2021-12-31 |
$1.07B |
$0.05B |
5.03% |
2021-09-30 |
$1.05B |
$0.05B |
4.46% |
2021-06-30 |
$1.03B |
$0.03B |
3.01% |
2021-03-31 |
$0.97B |
$0.00B |
0.21% |
2020-12-31 |
$0.96B |
$-0.01B |
-1.35% |
2020-09-30 |
$0.96B |
$-0.03B |
-3.53% |
2020-06-30 |
$0.96B |
$-0.04B |
-3.95% |
2020-03-31 |
$1.00B |
$-0.01B |
-0.70% |
2019-12-31 |
$1.00B |
$0.00B |
0.20% |
2019-09-30 |
$0.97B |
$0.02B |
2.27% |
2019-06-30 |
$0.95B |
$0.05B |
4.95% |
2019-03-31 |
$0.92B |
$0.05B |
5.45% |
2018-12-31 |
$0.88B |
$0.05B |
5.55% |
2018-09-30 |
$0.84B |
$0.05B |
5.71% |
2018-06-30 |
$0.80B |
$0.03B |
3.38% |
2018-03-31 |
$0.76B |
$0.03B |
3.42% |
2017-12-31 |
$0.73B |
$0.04B |
4.81% |
2017-09-30 |
$0.70B |
$0.03B |
4.89% |
2017-06-30 |
$0.67B |
$0.04B |
5.35% |
2017-03-31 |
$0.64B |
$0.04B |
5.49% |
2016-12-31 |
$0.60B |
$0.03B |
4.30% |
2016-09-30 |
$0.58B |
$0.02B |
3.94% |
2016-06-30 |
$0.56B |
$0.03B |
5.33% |
2016-03-31 |
$0.55B |
$0.03B |
5.64% |
2015-12-31 |
$0.54B |
$0.03B |
5.90% |
2015-09-30 |
$0.54B |
$0.04B |
6.89% |
2015-06-30 |
$0.53B |
$0.04B |
7.55% |
2015-03-31 |
$0.52B |
$0.03B |
6.53% |
2014-12-31 |
$0.51B |
$0.03B |
6.08% |
2014-09-30 |
$0.50B |
$0.03B |
5.43% |
2014-06-30 |
$0.48B |
$0.02B |
4.76% |
2014-03-31 |
$0.46B |
$0.02B |
4.96% |
2013-12-31 |
$0.45B |
$0.02B |
4.23% |
2013-09-30 |
$0.43B |
$0.01B |
3.02% |
2013-06-30 |
$0.41B |
$0.02B |
3.88% |
2013-03-31 |
$0.40B |
$0.02B |
4.96% |
2012-12-31 |
$0.40B |
$0.03B |
7.09% |
2012-09-30 |
$0.38B |
$0.03B |
8.33% |
2012-06-30 |
$0.38B |
$0.03B |
7.94% |
2012-03-31 |
$0.37B |
$0.03B |
8.70% |
2011-12-31 |
$0.36B |
$0.03B |
9.47% |
2011-09-30 |
$0.35B |
$0.03B |
9.46% |
2011-06-30 |
$0.33B |
$0.02B |
6.63% |
2011-03-31 |
$0.32B |
$0.02B |
6.33% |
2010-12-31 |
$0.30B |
$0.02B |
5.41% |
2010-09-30 |
$0.28B |
$0.02B |
6.74% |
2010-06-30 |
$0.28B |
$0.03B |
11.23% |
2010-03-31 |
$0.27B |
$0.03B |
11.65% |
2009-12-31 |
$0.26B |
$0.03B |
12.84% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$5.972B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|